Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer

S. Samuel Kim; Jacques Donnez; Pedro Barri; Antonio Pellicer; Pasquale Patrizio; Zev Rosenwaks; Peter Nagy; Tommaso Falcone; Claus Andersen; Outi Hovatta; Hamish Wallace; Dror Meirow; Debra Gook; Seok H. Kim; Chii Ruey Tzeng; Shuetu Suzuki; Bunpei Ishizuka; Marie Madeleine Dolmans

doi:10.1007/s10815-012-9786-y

Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer

S. Samuel Kim^*
, Jacques Donnez
, Pedro Barri
, Antonio Pellicer
, Pasquale Patrizio
, Zev Rosenwaks
, Peter Nagy
, Tommaso Falcone
, Claus Andersen
, Outi Hovatta
, Hamish Wallace
, Dror Meirow
, Debra Gook
, Seok H. Kim
, Chii Ruey Tzeng
, Shuetu Suzuki
, Bunpei Ishizuka
, Marie Madeleine Dolmans

^*Corresponding author for this work

University of Kansas
Université catholique de Louvain
USP Institut Universitari Dexeus
Instituto Universitario IVI
Yale University
Cornell University
Reproductive Biology Associates
Cleveland Clinic Foundation
University of Copenhagen
Karolinska Institutet
NHS Lothian
Sheba Medical Center at Tel Hashomer
Royal Women's Hospital
Seoul National University
Taipei Medical University
St. Marianna University School of Medicine

Research output: Contribution to journal › Article › peer-review

194 Scopus citations

Abstract

Fertility issues should be addressed to all patients in reproductive age before cancer treatment. In men, cryopreservation of sperm should be offered to all cancer patients in reproductive age regardless of the risk of gonadal failure. In women, the recommendation of fertility preservation should be individualized based on multiple factors such as the urgency of treatment, the age of the patient, the marital status, the regimen and dosage of cancer treatment.

Original language	English
Pages (from-to)	465-468
Number of pages	4
Journal	Journal of Assisted Reproduction and Genetics
Volume	29
Issue number	6
DOIs	https://doi.org/10.1007/s10815-012-9786-y
State	Published - Jun 2012
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Breast cancer
Cancer
Cancer survival
Chemotherapy
Fertility
Fertility preservation
GnRH agonist
Gonadal failure
Leukemia
Lymphoma
Oocyte cryopreservation
Ovarian tissue cryopreservation
Primary ovarian insufficiency

Access to Document

10.1007/s10815-012-9786-y

Cite this

Kim, S. S., Donnez, J., Barri, P., Pellicer, A., Patrizio, P., Rosenwaks, Z., Nagy, P., Falcone, T., Andersen, C., Hovatta, O., Wallace, H., Meirow, D., Gook, D., Kim, S. H., Tzeng, C. R., Suzuki, S., Ishizuka, B., & Dolmans, M. M. (2012). Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. Journal of Assisted Reproduction and Genetics, 29(6), 465-468. https://doi.org/10.1007/s10815-012-9786-y

@article{8179dc7e9ffc4d799928d0562166aca2,

title = "Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer",

abstract = "Fertility issues should be addressed to all patients in reproductive age before cancer treatment. In men, cryopreservation of sperm should be offered to all cancer patients in reproductive age regardless of the risk of gonadal failure. In women, the recommendation of fertility preservation should be individualized based on multiple factors such as the urgency of treatment, the age of the patient, the marital status, the regimen and dosage of cancer treatment.",

keywords = "Breast cancer, Cancer, Cancer survival, Chemotherapy, Fertility, Fertility preservation, GnRH agonist, Gonadal failure, Leukemia, Lymphoma, Oocyte cryopreservation, Ovarian tissue cryopreservation, Primary ovarian insufficiency",

author = "Kim, \{S. Samuel\} and Jacques Donnez and Pedro Barri and Antonio Pellicer and Pasquale Patrizio and Zev Rosenwaks and Peter Nagy and Tommaso Falcone and Claus Andersen and Outi Hovatta and Hamish Wallace and Dror Meirow and Debra Gook and Kim, \{Seok H.\} and Tzeng, \{Chii Ruey\} and Shuetu Suzuki and Bunpei Ishizuka and Dolmans, \{Marie Madeleine\}",

year = "2012",

month = jun,

doi = "10.1007/s10815-012-9786-y",

language = "אנגלית",

volume = "29",

pages = "465--468",

journal = "Journal of Assisted Reproduction and Genetics",

issn = "1058-0468",

publisher = "Springer",

number = "6",

}

Kim, SS, Donnez, J, Barri, P, Pellicer, A, Patrizio, P, Rosenwaks, Z, Nagy, P, Falcone, T, Andersen, C, Hovatta, O, Wallace, H, Meirow, D, Gook, D, Kim, SH, Tzeng, CR, Suzuki, S, Ishizuka, B & Dolmans, MM 2012, 'Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer', Journal of Assisted Reproduction and Genetics, vol. 29, no. 6, pp. 465-468. https://doi.org/10.1007/s10815-012-9786-y

TY - JOUR

T1 - Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer

AU - Kim, S. Samuel

AU - Donnez, Jacques

AU - Barri, Pedro

AU - Pellicer, Antonio

AU - Patrizio, Pasquale

AU - Rosenwaks, Zev

AU - Nagy, Peter

AU - Falcone, Tommaso

AU - Andersen, Claus

AU - Hovatta, Outi

AU - Wallace, Hamish

AU - Meirow, Dror

AU - Gook, Debra

AU - Kim, Seok H.

AU - Tzeng, Chii Ruey

AU - Suzuki, Shuetu

AU - Ishizuka, Bunpei

AU - Dolmans, Marie Madeleine

PY - 2012/6

Y1 - 2012/6

N2 - Fertility issues should be addressed to all patients in reproductive age before cancer treatment. In men, cryopreservation of sperm should be offered to all cancer patients in reproductive age regardless of the risk of gonadal failure. In women, the recommendation of fertility preservation should be individualized based on multiple factors such as the urgency of treatment, the age of the patient, the marital status, the regimen and dosage of cancer treatment.

AB - Fertility issues should be addressed to all patients in reproductive age before cancer treatment. In men, cryopreservation of sperm should be offered to all cancer patients in reproductive age regardless of the risk of gonadal failure. In women, the recommendation of fertility preservation should be individualized based on multiple factors such as the urgency of treatment, the age of the patient, the marital status, the regimen and dosage of cancer treatment.

KW - Breast cancer

KW - Cancer

KW - Cancer survival

KW - Chemotherapy

KW - Fertility

KW - Fertility preservation

KW - GnRH agonist

KW - Gonadal failure

KW - Leukemia

KW - Lymphoma

KW - Oocyte cryopreservation

KW - Ovarian tissue cryopreservation

KW - Primary ovarian insufficiency

UR - https://www.scopus.com/pages/publications/84864951338

U2 - 10.1007/s10815-012-9786-y

DO - 10.1007/s10815-012-9786-y

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 22648282

AN - SCOPUS:84864951338

SN - 1058-0468

VL - 29

SP - 465

EP - 468

JO - Journal of Assisted Reproduction and Genetics

JF - Journal of Assisted Reproduction and Genetics

IS - 6

ER -

Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this